(Total Views: 478)
Posted On: 05/26/2025 1:11:51 AM
Post# of 154053
Temozolomide is the only FDA-approved therapy with a survival benefit for adult patients with glioblastoma.
*Temozolomide (Temodar) is an oral alkylating agent approved by the FDA for use in the first-line treatment of glioblastoma multiforme as well as for recurrent anaplastic astrocytoma.
*Among patients 65 to 70 years of age, the median overall survival was 8.7 months with radiotherapy plus temozolomide and 8.3 months with radiotherapy alone
Very confident LL will far better combo on all stages of glios, up to stage 5 --- Glioblastoma
*Temozolomide (Temodar) is an oral alkylating agent approved by the FDA for use in the first-line treatment of glioblastoma multiforme as well as for recurrent anaplastic astrocytoma.
*Among patients 65 to 70 years of age, the median overall survival was 8.7 months with radiotherapy plus temozolomide and 8.3 months with radiotherapy alone
Very confident LL will far better combo on all stages of glios, up to stage 5 --- Glioblastoma
(4)
(0)
